The issue was conducted under Aegon’s US Shelf Registration through the sale of 173,604,912 new common shares of Aegon N.V. with a nominal value of EUR 0.12. The shares were sold at a price of EUR 5.20 per share.
The proceeds of EUR 903 million will be used to fund part of the repurchase of 375 million convertible core capital securities provided by the Dutch State.
Application has been made to list the new shares on Euronext Amsterdam, the principal market for Aegon’s common shares. The issue is expected to be settled on March 1, 2011, and the new shares are expected to be admitted to trading as of that date.
Morgan Stanley acted as Sole Global Coordinator and Joint Book runner for the offering. Deutsche Bank and JP Morgan acted as Joint Book runners. A prospectus for the offering may be obtained from Morgan Stanley, 20 Bank Street, Canary Wharf, London, E14 4AD, United Kingdom. In addition, the prospectus may be obtained from Aegon’s website, www.Aegon.com.
Registration statement
Aegon has filed a registration statement (including a prospectus) with the SEC for the equity offering described in this presentation. Before you invest, you should read the prospectus in that registration statement and other documents Aegon has filed with the SEC for more complete information about Aegon and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, Aegon, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free:+1-866-718-1649.
